Source link : https://www.newshealth.biz/health-news/the-data-are-clear-patients-regain-weight-after-stopping-glp-1-drugs/
This story is part of a series called “Ozempic: Weighing the Risks and Benefits.” It was produced in part through a grant from the NIHCM Foundation. Looking at the data from clinical trials of new GLP-1 agonists, it’s clear that patients will need to stay on the drugs to maintain their weight loss, experts said. […]
Author : News Health
Publish date : 2024-09-26 19:54:27
Copyright for syndicated content belongs to the linked Source.
in Health